Today: 1 May 2026
CoreWeave stock price forecast: Wall Street still sees $121 target after Nvidia Rubin news, but shares wobble
7 January 2026
2 mins read

CoreWeave stock price forecast: Wall Street still sees $121 target after Nvidia Rubin news, but shares wobble

New York, Jan 7, 2026, 15:29 EST — Regular session

  • CoreWeave (CRWV) shares were down about 0.6% at $77.51, after trading between $75.77 and $79.92.
  • Analysts’ 12-month targets tracked by Benzinga run from $36 to $180, with an average around $121.
  • Investors are weighing Nvidia Rubin rollout plans, shifting analyst views and insider-sale notices, with U.S. jobs data on Jan. 9 the next macro test.

CoreWeave shares were down about 0.6% at $77.51 in afternoon trading on Wednesday after swinging between $75.77 and $79.92. The CoreWeave stock price forecast looks messy: analyst targets tracked by Benzinga ranged from $36 to $180 over the past quarter, with an average of $121.48, down from $142. 

Why it matters now: CoreWeave just put new product headlines back on the tape, tying its outlook even tighter to Nvidia’s chip roadmap. The company said it plans to add Nvidia’s next Rubin platform to its cloud and expects to deploy it in the second half of 2026, aiming at demanding workloads such as large-scale inference and “agentic” AI. CoreWeave

Rates are the other driver, and it’s a bad week to ignore them. ADP data on Wednesday showed U.S. private payrolls rose less than expected in December, and the government’s employment report is due on Friday, Jan. 9. 

Analysts are split on whether the growth story is worth the balance-sheet strain. Gil Luria at D.A. Davidson upgraded CoreWeave to neutral from underperform and lifted his price target to $68 from $36, even though the stock traded above that level; he still warned of an “inevitable reckoning” if returns stay below the cost of capital, Barron’s reported. Barron’s

Jefferies struck a different tone: keep the buy, trim the numbers. Analyst Brent Thill lowered his price target to $120 from $155 and wrote that 2026 could be “another year of gradual AI monetization,” while flagging disintermediation fears — customers skipping intermediaries and doing more of the work themselves. TipRanks

A separate filing kept the insider-sales angle in play. A Form 144 dated Jan. 5 showed an officer-related entity, CANIS MINOR 2025 GRAT, planned to sell 8,335 shares through Morgan Stanley, valued at about $661,000; Form 144 is a notice of an intended sale under SEC Rule 144 and does not mean the shares have already been sold. 

For traders, the near-term map is simple even if the fundamentals are not. The stock has churned inside a roughly $4 band all day; $80 is the next psychological level on the upside, while the $75–$76 area is the first line on the downside.

But the risk case is sitting in plain sight across the sector. Investors have been questioning whether the surge in data-center spending will translate into durable profits, with worries that run from debt and valuation to power constraints — themes that have kept AI-linked stocks volatile into early 2026. 

Next comes the macro calendar that tends to set the tone for rate-sensitive growth stocks: the U.S. CPI report on Jan. 13 and the Federal Reserve’s Jan. 27–28 meeting, with the Jan. 9 jobs report first in line. 

Stock Market Today

  • 3 Vanguard ETFs to Shield Your Portfolio From a Possible Stock Market Crash
    May 1, 2026, 12:10 PM EDT. As the S&P 500 hits record highs, warning signs such as labor market stagnation, rising inflation, and geopolitical tensions weigh on investors. Many hold heavy tech exposures, increasing vulnerability to downturns. Vanguard offers three ETFs designed for protection. The Vanguard High Dividend Yield ETF (VYM) targets top-yielding equities, often more stable in bear markets. The Vanguard Health Care ETF (VHT) focuses on recession-resilient healthcare companies whose revenues persist. Lastly, the Vanguard Short-Term TIPS ETF invests in Treasury inflation-protected securities to hedge against inflation, now elevated by global risks. These ETFs provide diversification and defensive postures to help investors navigate potential volatility ahead.

Latest article

Tempus AI’s Big May: Why Q1 Results and First Investor Day Put TEM Stock in Focus

Tempus AI’s Big May: Why Q1 Results and First Investor Day Put TEM Stock in Focus

1 May 2026
Tempus AI will report first-quarter results on May 5 and hold its first investor day on May 29. Merck’s CEO highlighted Tempus in remarks on the drugmaker’s AI efforts in precision oncology. Tempus shares traded near $55.44 Friday, with a market value of about $9.7 billion. The company reported 2025 revenue of $1.27 billion and forecast $1.59 billion for 2026.
Ciena Corporation Stock Faces $416 Reality Check as AI Network Push Heads to Brazil

Ciena Corporation Stock Faces $416 Reality Check as AI Network Push Heads to Brazil

1 May 2026
Rothschild & Co Redburn initiated Ciena with a Neutral rating and a $416 target, about 22% below Friday’s $534.43 share price, citing that much of the optical-networking upside is already priced in. Ciena reported Q1 revenue of $1.43 billion, up 33%, and raised its 2026 forecast. The company will showcase new optical products at ABRINT 2026 in São Paulo next week.
Meta stock price forecast: China review of Manus deal drags META as Wall Street targets $822
Previous Story

Meta stock price forecast: China review of Manus deal drags META as Wall Street targets $822

Apple stock price forecast: AAPL slides as memory costs rise and earnings near
Next Story

Apple stock price forecast: AAPL slides as memory costs rise and earnings near

Go toTop